Pericijazin
Izgled
(Preusmjereno sa stranicePericiazin)
Klinički podaci | |||
---|---|---|---|
Robne marke | Neulactil, Neuleptil, Yaz | ||
AHFS/Drugs.com | Monografija | ||
Identifikatori | |||
CAS broj | 2622-26-6 | ||
ATC kod | N05AC01 | ||
PubChem[1][2] | 4747 | ||
DrugBank | DB01608 | ||
ChemSpider[3] | 4585 | ||
ChEBI | CHEBI:31981 | ||
Hemijski podaci | |||
Formula | C21H23N3OS | ||
Mol. masa | 365,492 | ||
SMILES | eMolekuli&PubHem | ||
| |||
Fizički podaci | |||
Tačka topljenja | 116-117 °C (-63 °F) | ||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Pericijazinjeorgansko jedinjenje,koje sadrži 21atomugljenikai imamolekulsku masuod 365,492Da.[4][5]
Osobina | Vrednost |
---|---|
Broj akceptora vodonika | 5 |
Broj donora vodonika | 1 |
Broj rotacionih veza | 4 |
Particioni koeficijent[6](ALogP) | 3,4 |
Rastvorljivost[7](logS,log(mol/L)) | -4,7 |
Polarna površina[8](PSA,Å2) | 75,8 |
- ↑Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.”.Drug Discov Today15(23-24): 1052-7.DOI:10.1016/j.drudis.2010.10.003.PMID20970519.
- ↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4:217-241.DOI:10.1016/S1574-1400(08)00012-1.
- ↑Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010).„Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”.J Cheminform2(1): 3.DOI:10.1186/1758-2946-2-3.PMID20331846.
- ↑Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011).„DrugBank 3.0: a comprehensive resource for omics research on drugs”.Nucleic Acids Res.39(Database issue): D1035-41.DOI:10.1093/nar/gkq1126.PMC3013709.PMID21059682.
- ↑David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008).„DrugBank: a knowledgebase for drugs, drug actions and drug targets”.Nucleic Acids Res36(Database issue): D901-6.DOI:10.1093/nar/gkm958.PMC2238889.PMID18048412.
- ↑Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998).„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”.J. Phys. Chem. A102:3762-3772.DOI:10.1021/jp980230o.
- ↑Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001).„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”.Chem Inf. Comput. Sci.41:1488-1493.DOI:10.1021/ci000392t.PMID11749573.
- ↑Ertl P., Rohde B., Selzer P. (2000).„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”.J. Med. Chem.43:3714-3717.DOI:10.1021/jm000942e.PMID11020286.
- Hardman JG, Limbird LE, Gilman AG. (2001).Goodman & Gilman's The Pharmacological Basis of Therapeutics(10 izd.). New York: McGraw-Hill.DOI:10.1036/0071422803.ISBN0-07-135469-7.
- Thomas L. Lemke, David A. Williams, ur. (2007).Foye's Principles of Medicinal Chemistry(6 izd.). Baltimore: Lippincott Willams & Wilkins.ISBN0-7817-6879-9.